XML 32 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Mar. 31, 2013
Group
Mar. 31, 2012
Dec. 31, 2012
May 30, 2012
Mar. 31, 2013
Africa [Member]
Mar. 31, 2012
Africa [Member]
Mar. 31, 2013
Asia [Member]
Mar. 31, 2012
Asia [Member]
Mar. 31, 2013
Europe [Member]
Mar. 31, 2012
Europe [Member]
Mar. 31, 2013
North America [Member]
Mar. 31, 2012
North America [Member]
Mar. 31, 2013
South America [Member]
Mar. 31, 2012
South America [Member]
Mar. 31, 2013
Cost of Goods Sold [Member]
Mar. 31, 2012
Cost of Goods Sold [Member]
Mar. 31, 2013
Research and Development Expense [Member]
Mar. 31, 2012
Research and Development Expense [Member]
Mar. 31, 2013
Selling, General and Administrative Expenses [Member]
Mar. 31, 2012
Selling, General and Administrative Expenses [Member]
Mar. 31, 2013
Stock Options [Member]
Mar. 31, 2012
Stock Options [Member]
Dec. 31, 2012
Stock Options [Member]
Mar. 31, 2013
1999 Stock Option Plan [Member]
Stock Options [Member]
Mar. 31, 2013
2008 Stock Incentive Plan [Member]
Stock Options [Member]
Dec. 31, 2008
2008 Stock Incentive Plan [Member]
Stock Options [Member]
Basis of Presentation [Abstract]                                                    
Reverse stock split conversion ratio       1-for-8                                            
Common stock outstanding before reverse stock split (in shares)       63,967,263                                            
Common stock outstanding after reverse stock split (in shares)       7,995,918                                            
Inventories [Abstract]                                                    
Raw materials $ 1,406,094   $ 1,418,071                                              
Work in process 762,401   561,530                                              
Finished goods 432,994   508,470                                              
Inventories 2,601,489   2,488,071                                              
Earnings (Loss) Per Share [Abstract]                                                    
Reverse stock split conversion ratio       1-for-8                                            
Common stock outstanding before reverse stock split (in shares)       63,967,263                                            
Common stock outstanding after reverse stock split (in shares)       7,995,918                                            
Summary of weighted average shares used for computation of basic and diluted earnings per share [Abstract]                                                    
Basic (in shares) 8,062,984 7,934,331                                                
Diluted (in shares) 8,699,209 8,512,374                                                
Summary of common share equivalent basis, used in diluted per share computations [Abstract]                                                    
1999 and 2008 Plan Stock Options (in shares) 636,225 578,043                                                
Options and warrants excluded from calculation of diluted per common share equivalent because the effect would have been anti-dilutive (in shares) 118,360 198,278                                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                    
Number of shares authorized under the plan (in shares)                                               375,000 750,000 625,000
Number of stock options outstanding under the plan (in shares)                                         712,189   731,646 93,750 618,439  
Maximum period of stock option issuance after adoption of SOP                                               10 years    
Increase in number of shares authorized (in shares)                                                 125,000  
Number of stock options exercised under the plan (in shares)                                         64,359       105,551  
Options or shares still available to be issued (in shares)                                                 26,010  
Weighted average estimated grant-date fair value of stock options granted (in dollars per share) $ 4.08 $ 3.20                                                
Assumptions made in calculating fair values of options [Abstract]                                                    
Expected term                                         4 years 9 months 18 days 5 years        
Expected volatility (in hundredths)                                         100.91% 115.77%        
Expected dividend yield (in hundredths)                                         0.00% 0.00%        
Risk-free interest rate (in hundredths)                                         0.57% 0.36%        
Stock options, number of shares [Roll forward]                                                    
Outstanding, beginning of period (in shares)                                         731,646          
Granted (in shares) 30,000                                       46,360          
Exercised (in shares)                                         (64,359)       (105,551)  
Forfeited/expired/cancelled (in shares)                                         (1,458)          
Outstanding, end of period (in shares)                                         712,189   731,646 93,750 618,439  
Exercisable, end of period (in shares)                                         474,867          
Stock options, outstanding, weighted average exercise price per share [Roll Forward]                                                    
Outstanding, beginning of period (in dollars per share)                                         $ 2.12          
Granted (in dollars per share)                                         $ 5.48          
Exercised (in dollars per share)                                         $ 1.50          
Forfeited/expired/cancelled (in dollars per share)                                         $ 1.04          
Outstanding, end of period (in dollars per share)                                         $ 2.39   $ 2.12      
Exercisable, end of period (in dollars per share)                                         $ 1.60          
Stock options, additional disclosure [Abstract]                                                    
Outstanding, weighted average remaining contractual term, beginning of period                                         2 years 4 months 2 days   2 years 2 months 9 days      
Outstanding, weighted average remaining contractual term, end of period                                         2 years 4 months 2 days   2 years 2 months 9 days      
Exercisable, weighted average remaining contractual term, end of period                                         1 year 7 months 10 days          
Outstanding, aggregate intrinsic value, beginning of period                                         3,460,686          
Outstanding, aggregate intrinsic value, end of period                                         1,892,082   3,460,686      
Exercisable, aggregate intrinsic value, end of period                                         1,637,100          
Net unrecognized compensation cost                                         356,000          
Weighted average period for recognition of net unrecognized compensation cost (in years)                                         9 months 18 days          
Total fair value of stock options vested during period                                         90,000 104,000        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]                                                    
Allocated share-based compensation expense 138,000 133,000                         30,000 15,000 40,000 48,000 68,000 70,000            
Revenues from External Customers [Line Items]                                                    
Number of product groups 1                                                  
Net product sales 6,313,190 6,363,152     847,322 1,077,736 19,266 12,478 7,605 25,578 2,819,519 2,720,760 2,619,478 2,526,600                        
Summary of accounts payable and accrued liabilities [Abstract]                                                    
Accounts payable - suppliers 1,452,610   1,686,431                                              
Accrued commissions 262,549   238,150                                              
Accrued royalties / license fees 758,047   583,923                                              
Accrued payroll 158,173   262,439                                              
Accrued vacation 217,008   181,636                                              
Accrued bonuses 162,750   155,663                                              
Accrued expenses - other 178,524   195,681                                              
TOTAL $ 3,189,661   $ 3,303,923